About 15 percent of people with pancreatic cancer may benefit from therapy targeting a newly identified gene signature, scientists say. This sub-group of pancreatic cancer patients who possess a strong angiogenic gene signature could benefit from personalized therapies that cut off the pathways that feed the cancer’s growth, they note.
from Top Health News — ScienceDaily http://bit.ly/1MVFmJY via Naturally Increase Breast Size At Home
from Tumblr http://bit.ly/1wl5nb0
No comments:
Post a Comment